* admitted to hospital or in an ed for more than 24 hours * previously randomized to cantreatcovid * currently participating in a clinical trial of a therapeutic agent for acute sars-cov-2 infection that is not/suspected not compatible with the study therapeutics * already taking a study therapeutic or contraindication to a study therapeutic * inability for participant or caregiver to provide informed consent paxlovid

* admitted to hospital or in an ed for more than 24 hours * previously randomized to cantreatcovid * currently participating in a clinical trial of a therapeutic agent for acute sars-cov-2 infection that is not/suspected not compatible with the study therapeutics * already taking a study therapeutic or contraindication to a study therapeutic * inability for participant or caregiver to provide informed consent paxlovid

admitted to hospital or in an ed for more than 24 hours previously randomized to cantreatcovid currently participating in a clinical trial of a therapeutic agent for acute sars-cov-2 infection that is not/suspected not compatible with the study therapeutics already taking a study therapeutic or contraindication to a study therapeutic inability for participant or caregiver to provide informed consent paxlovid

admitted to hospital or in an ed for more than 24 hours previously randomized to cantreatcovid currently participating in a clinical trial of a therapeutic agent for acute sars-cov-2 infection that is not/suspected not compatible with the study therapeutics already taking a study therapeutic or contraindication to a study therapeutic inability for participant or caregiver to provide informed consent paxlovid